Yatharth Hospitals Q1FY27 Revenue Surges 51% YoY to ₹392.7 Crore; Declares Maiden Dividend
Yatharth Hospitals reported Q1FY27 revenue of ₹392.7 crore, up 51% YoY, and EBITDA of ₹91.7 crore, up 39% YoY. PAT stood at ₹45.4 crore, up 8% YoY. The company declared its maiden interim dividend of 5% and approved new ESOP schemes. Faridabad Sector-20 achieved EBITDA breakeven.
Significant YoY growth in key financial metrics, achievement of breakeven for a new facility, and declaration of maiden dividend are material events that are likely to positively impact investor sentiment and the company's stock.
The company reported strong YoY growth in revenue, EBITDA, and PAT, along with achieving EBITDA breakeven for a new facility and declaring its maiden interim dividend, indicating positive financial performance and strategic execution.
Yatharth Hospital & Trauma Care Services Ltd. announced its financial results for the quarter ending June 30, 2026, reporting a stellar performance with revenue growing 51% year-on-year (YoY) to ₹3,927 million (₹392.7 crore) and EBITDA increasing by 39% YoY to ₹917 million (₹91.7 crore).
The company's revenue growth was driven by strong ramp-up across its new hospitals, including Greater Faridabad, Model Town New Delhi, Faridabad Sector-20, and Agra, which contributed ₹1,067 million (₹106.7 crore) or 27% to the group's revenue. Mature hospitals also sustained momentum, growing 22% YoY. The Group's Average Revenue Per Occupied Bed (ARPOB) reached ₹34,758, up 7% YoY, with premium NCR hospitals in Noida Extension and New Delhi achieving the ₹50,000 mark.
Faridabad Sector-20 achieved EBITDA breakeven in a record nine months of operations, and the Agra hospital delivered over 20% EBITDA margin within its first full quarter of integration. Adjusted EBITDA margin, excluding ramp-up losses, stood strong at 28.1%. Profit After Tax (PAT) reached a record ₹454 million (₹45.4 crore), an 8% YoY increase, reflecting the underlying strength of the expanded network. Cash Profits grew by 29% YoY.
In recognition of the healthy performance, the Board of Directors has approved the company's maiden interim dividend of 5% of the face value. Additionally, the Board approved the grant of ESOPs under the ESOP Scheme 2024 and the launch of a new ESOP Scheme 2026 to attract and retain talent.
Mr. Yatharth Tyagi, Whole Time Director, commented that FY27 has commenced on a strong footing, with both mature and newly added hospitals contributing meaningfully. He highlighted the progress of newer facilities, with Faridabad Sector-20 achieving EBITDA breakeven and Agra hospital contributing to profits. He also noted that premium NCR hospitals are approaching the ₹50,000 ARPOB mark, validating the acquisition playbook.
The company will host an earnings conference call on August 11, 2026, at 11:00 am IST to discuss performance and answer participant questions.
What to do with a filing like this
Yatharth Hospital & Trauma Care Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Yatharth Hospital & Trauma Care Services Limited. Read the original for the full detail.